Surgery Partners (SGRY) Short term Debt (2014 - 2026)

Surgery Partners has disclosed Short term Debt across 13 years of filings, most recently posting $100.4 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $100.4 million, down 3.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $100.4 million (down 3.37% YoY), and the FY2025 annual result was $99.3 million, down 2.07% from the prior year.
• Short term Debt came in at $100.4 million for Q1 2026 at Surgery Partners, up from $99.3 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $116.9 million in Q3 2022 to a low of $62.1 million in Q3 2023.
• The 5-year median for Short term Debt is $92.4 million (2024), against an average of $86.1 million.
• Across the five-year window, Short term Debt soared 92.27% in 2022 and sank 46.88% in 2023, its largest moves.
• Surgery Partners' Short term Debt stood at $62.8 million in 2022, then grew by 16.72% to $73.3 million in 2023, then soared by 38.34% to $101.4 million in 2024, then dropped by 2.07% to $99.3 million in 2025, then climbed by 1.11% to $100.4 million in 2026.
• The last three Short term Debt figures came in at $100.4 million (Q1 2026), $99.3 million (Q4 2025), and $103.0 million (Q3 2025), per Business Quant data.